Instil Bio Inc. Sees Investment Surge Amid Volatile Stock Performance
Instil Bio, a clinical-stage biopharmaceutical company, has seen significant investment activity and stock price volatility, with a recent 52-week high of $92 USD and a current market capitalization of $85.5 million USD.
2 minutes to read